Tillotts Pharma AG announces launch of Asacol 800 mg tablets in the People’s Republic of China

Tillotts Pharma enters China

Tillotts Pharma AG, part of the Japanese Zeria Group, is pleased to announce the recent launch of Asacol® 800 mg tablets (mesalazine) as first-line treatment for mild to moderate ulcerative colitis (UC) in the People’s Republic of China (“China”).

After announcing the successful partnership of Tillotts and Menarini in October 2019, and regulatory approval of Asacol® 800 mg in April 2020, the launch of the tablets represents a major milestone for both companies. Bringing Asacol® to the market began several years ago with the conduct of two Phase III studies in the local population. The introduction of this high strength mesalazine tablet formulation to the Chinese market is expected to optimise the therapeutic options of patients living with UC in China.

Mattias Norrman, Chief Operations Officer at Tillotts, said, “We are very excited that we have now launched Asacol in China and made it available to Chinese patients. This has been achieved through the close partnership between Tillotts and Menarini and the efforts and continued dedication of the teams involved. Providing the highest strength mesalazine tablet in the Chinese market may help improve patient adherence to chronic ulcerative colitis treatment. It is always a great satisfaction to ensure that UC patients around the world receive new first-line treatment opportunities.”

Mattias Norrman added, “The commercial launch of Asacol® tablets will bring new treatment options in tablet formulation to clinicians. There is a substantial need for new treatment options in UC. According to statistics from the Chinese Center for Disease Control and Prevention, it is estimated that by 2025, the number of patients in China with IBD; a type of chronic non-specific intestinal inflammation, including ulcerative colitis and Crohn’s disease, will reach 1.5 million[1].”

Tags : #TillotaPharma #China #Asacol #AsacolLaunchedChina #Menarini #smitakumar #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-


Trending Now

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.May 20, 2022
Hanuman raises over $.5 million to expand its emergency medical response services in Bihar, Jharkand and UP May 20, 2022
Sudden Infant Death Syndrome (SIDS) – Causes and preventive methodsMay 20, 2022
Healthcare Innovation Challenge: Data's Expanding Role in the Healthcare SectorMay 20, 2022
Homeopathy in Pregnancy - Homeopathy Treatment | MedicircleMay 20, 2022
MetroMedi launches the MetroMedi Relief platform for mental and sexual health wellbeing.May 20, 2022
Top Health Benefits for Butter milk May 20, 2022
Sumit Agarwal- Born with Cerabral Palsy to today being an acclaimed entrepreneur in the public relations industry in IndiaMay 20, 2022
Five eye hospitals in the Tri-city region have been acquired by Dr. Agarwal's Eye Hospital.May 19, 2022
World Family Doctor Day, 2022 – Family doctor makes care easily accessible May 19, 2022
Adani Enterprises will explore the healthcare industry.May 19, 2022
Tips for Weight Loss May 19, 2022
What should be the diet during menopause? May 19, 2022
5 Tips To Get Rid Of Cracked Heels In SummerMay 19, 2022
How is meditation beneficial in reducing low blood pressure?May 18, 2022
Why should we not eat mushrooms because of kidney disease? May 18, 2022
Zinc Deficiency Symptoms in the BodyMay 18, 2022
Dawaa Dost : Making drugs more accessible and affordable.May 18, 2022
Control and Manage HIV with ART therapy - MedicircleMay 18, 2022
Top 5 Solutions for Hair Detox May 17, 2022